KURA — Kura Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Kura Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	633	518	438	424	727
Prepaid Expenses
Total Current Assets	637	522	446	432	745
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.36	8.25	6.38	8.85	7.49
Other Long Term Assets
Total Assets	647	534	456	449	760
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26	22.5	24.1	35.3	78.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	36.3	27.4	36	51.7	347
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	611	507	420	397	414
Total Liabilities & Shareholders' Equity	647	534	456	449	760
Total Common Shares Outstanding